|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0017262,
umls-concept:C0030705,
umls-concept:C0185117,
umls-concept:C0220901,
umls-concept:C0237881,
umls-concept:C0278828,
umls-concept:C0332293,
umls-concept:C0750502,
umls-concept:C1130454,
umls-concept:C1521750,
umls-concept:C2911684
|
|
pubmed:issue |
2 Pt 2
|
|
pubmed:dateCreated |
2011-7-7
|
|
pubmed:abstractText |
To evaluate the expression of the human equilibrative nucleoside transporter 1 (hENT1) and excision repair cross complementing 1 (ERCC1) as possible prognostic factors for patients with metastatic bladder cancer treated with gemcitabine-cisplatin-based combination chemotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antimetabolites, Antineoplastic,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin,
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Deoxycytidine,
http://linkedlifedata.com/resource/pubmed/chemical/ERCC1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Endonucleases,
http://linkedlifedata.com/resource/pubmed/chemical/Equilibrative Nucleoside...,
http://linkedlifedata.com/resource/pubmed/chemical/gemcitabine
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1464-410X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
© 2010 THE AUTHORS. BJU INTERNATIONAL © 2010 BJU INTERNATIONAL.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
108
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
E110-6
|
|
pubmed:meshHeading |
pubmed-meshheading:21166756-Adult,
pubmed-meshheading:21166756-Aged,
pubmed-meshheading:21166756-Aged, 80 and over,
pubmed-meshheading:21166756-Antimetabolites, Antineoplastic,
pubmed-meshheading:21166756-Antineoplastic Agents,
pubmed-meshheading:21166756-Cisplatin,
pubmed-meshheading:21166756-DNA-Binding Proteins,
pubmed-meshheading:21166756-Deoxycytidine,
pubmed-meshheading:21166756-Endonucleases,
pubmed-meshheading:21166756-Equilibrative Nucleoside Transporter 1,
pubmed-meshheading:21166756-Female,
pubmed-meshheading:21166756-Humans,
pubmed-meshheading:21166756-Male,
pubmed-meshheading:21166756-Middle Aged,
pubmed-meshheading:21166756-Prognosis,
pubmed-meshheading:21166756-Retrospective Studies,
pubmed-meshheading:21166756-Survival Analysis,
pubmed-meshheading:21166756-Treatment Outcome,
pubmed-meshheading:21166756-Urinary Bladder Neoplasms
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
The prognostic significance of human equilibrative nucleoside transporter 1 expression in patients with metastatic bladder cancer treated with gemcitabine-cisplatin-based combination chemotherapy.
|
|
pubmed:affiliation |
Department of Urology, Wakayama Medical University, Wakayama, Japan. nmatsumu@wakayama-med.ac.jp
|
|
pubmed:publicationType |
Journal Article
|
